Archive

vol. In Press , issue In Press
In Press (In Press), 15 articles.

Important Notes: 

  • "In Press" articles are accepted and peer-reviewed articles that are not yet assigned to specific volumes/issues. They are citable using DOI. Read more.
  • Comments from author(s) or editor(s) will be applied in this state.
  • These articles could be subjected to postpone or even withdraw from further publication process based on the editorial board's decision.
  • The "In Press" article does not guarantee any final decision and cannot be used as official acceptance.
09
Sep
2023
Iran J Pharm Res

Cerasome Versus Liposome: A Comparative Pharmacokinetic Analysis Following Intravenous Administration into Rats

Shima Bahri, Erfan Abdollahizad, Iman Mahlooji, Elham Rezaee ORCID , Zahra Abbasian, Simin Dadashzadeh ORCID *
|
Uncorrected Proof scheduled for In Press (In Press)
28
Oct
2023
Iran J Pharm Res

In Vitro Chondrogenic Differentiation of Human Adipose-Derived Stem Cells by Diacerein

Ali Honarpardaz ORCID , Morteza Daliri Joupari ORCID * , Sajjad Tavakkoli
|
Uncorrected Proof scheduled for In Press (In Press)
14
Oct
2023
Iran J Pharm Res

The Efficacy and Safety of Propranolol in Treating Infantile Hemangioma: A Prospective Study

Mohammad Reza Khalilian ORCID , Fariba Esmaeili ORCID , Mohamad Reza Vahidi ORCID , Mohsen Rouzrokh ORCID , Elham Abdoulahzadeh ORCID , Hadi Pashapour ORCID , et al.
|
Uncorrected Proof scheduled for In Press (In Press)
30
Oct
2023
Iran J Pharm Res

Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial

Setayesh Sadeghi, Fatemeh Mohammadian, Mehdi Tehrani-Doost ORCID , Kheirollah Gholami, Niayesh Mohebbi *
|
Uncorrected Proof scheduled for In Press (In Press)
11
Oct
2023
Iran J Pharm Res

Evaluation of the Relationship Between Serum miR-200b-3p and miR-214-3p Expression Levels with Soluble ACE2 and TMPRSS2 in COVID-19 Patients

Faezeh Mortazavi ORCID , Mohsen Soltanshahi ORCID , Gholamhossein Tamaddon ORCID *
|
Uncorrected Proof scheduled for In Press (In Press)
14
Oct
2023
Iran J Pharm Res

Synthesis and Biological Evaluation of New Nitroimidazole Derivatives as Anti-Helicobacter pylori Agents Against Metronidazole-Resistant Strains

Zahra Bayati, Salimeh Amidi ORCID , Mahnaz Shahabimehr, Masoud Alebouyeh ORCID , Arash Mahboubi ORCID * , Sayyed Abbas Tabatabai ORCID **
|
Uncorrected Proof scheduled for In Press (In Press)
10
Nov
2023
Iran J Pharm Res

Different Modes of Mechanism of Gamma-Mangostin and Alpha-Mangostin to Inhibit Cell Migration of Triple-Negative Breast Cancer Cells Concerning CXCR4 Downregulation and ROS Generation

Sarmoko Sarmoko, Dhania Novitasari, Manami Toriyama, Muhamad Salman Fareza, N.A Choironi, Hiroshi Itoh, et al.
|
Uncorrected Proof scheduled for In Press (In Press)
30
Oct
2023
Iran J Pharm Res

The Effects of the Fraction Isolated from Iranian Buthotus shach Scorpion Venom on Synaptic Plasticity, Learning, Memory, and Seizure Susceptibility

Elmira Heidarli, Hossein Vatanpour * , Nafiseh Nasrabadi ORCID , Maha Soltani, Saeed Tahmasebi, Mehrdad Faizi ORCID **
|
Uncorrected Proof scheduled for In Press (In Press)
31
Oct
2023
Iran J Pharm Res

Preparation and in Vitro Property Research of Cholic Acid Nanoparticles with Dual Functions of Hemostasis and Antibacterial

Jin Ma, Cong Wang, Tieying Yin, Yang Jiang, Wanjun Yu, Xiaoyu Zhang, et al.
|
Uncorrected Proof scheduled for In Press (In Press)
14
Nov
2023
Iran J Pharm Res

Glucose Metabolism in Acute Myeloid Leukemia Cell Line Is Regulated via Combinational PI3K/AKT/mTOR Pathway Inhibitors

Abbas Ranjbar, Mohsen Soltanshahi ORCID , Saeid Taghiloo ORCID * , Hossein Asgarian-Omran ORCID **
|
Uncorrected Proof scheduled for In Press (In Press)
08
Nov
2023
Iran J Pharm Res

Cost-Utility Analysis of Mirabegron Compared to Solifenacin in the Treatment of Overactive Bladder (OAB) in Iran

Zahra Karimi Majd ORCID , Ghader Mohammadnezhad ORCID , Saeed Taheri ORCID , Nazila Yousefi ORCID *
|
Uncorrected Proof scheduled for In Press (In Press)
11
Nov
2023
Iran J Pharm Res

Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion

Iman Ansari ORCID , Ezzatalsadat Hajiseid Javadi ORCID , Hamideh Pakniat ORCID * , Ali Emami ORCID , Fatemeh Ranjkesh ORCID , Simindokht Molaverdikhani ORCID
|
Uncorrected Proof scheduled for In Press (In Press)
11
Nov
2023
Iran J Pharm Res

Antifatigue Effects of the Aqueous Extracts of Myrtle Berries, Apple and Clove: An Animal Study

Akram Alembagheri ORCID , Homa Hajimehdipour ORCID , Mona Khoramjouy, Somayeh Esmaeili ORCID * , Mehrdad Faizi ORCID **
|
Uncorrected Proof scheduled for In Press (In Press)
20
Nov
2023
Iran J Pharm Res

Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks

Roozbeh Heidarzadehpilehrood ORCID , Maryam Pirhoushiaran ORCID , Malina Binti Osman ORCID , King-Hwa Ling ORCID , Habibah Abdul Hamid ORCID *
|
Uncorrected Proof scheduled for In Press (In Press)
30
Nov
2023

Developing a Discrete Choice Experiment Instrument for Evaluating Patients’ Preferences in Precision Oncology

Zahra Karimi Majd ORCID , Nazila Yousefi ORCID , Mohammad Peikanpour ORCID , Mohammad Sistanizad ORCID , Ghader Mohammadnezhad ORCID , Behniya Azadmehr, et al.
|
Uncorrected Proof scheduled for 22 (1)